Skip to main navigation Skip to search Skip to main content

Oligomeric nucleic acids as antivirals

Alessandra Mescalchin, Tobias Restle*

*Corresponding author for this work

    Abstract

    Based on the natural functions and chemical characteristics of nucleic acids, a variety of novel synthetic drugs and tools to explore biological systems have become available in recent years. To date, a great number of antisense oligonucleotides, RNA interference-based tools, CpG-containing oligonucleotides, catalytic oligonucleotides, decoys and aptamers has been produced synthetically and applied successfully for understanding and manipulating biological processes and in clinical trials to treat a variety of diseases. Their versatility and potency make them equally suited candidates for fighting viral infections. Here, we describe the different types of nucleic acid-based antivirals, their mechanism of action, their advantages and limitations, and their future prospects.

    Original languageEnglish
    JournalMolecules
    Volume16
    Issue number2
    Pages (from-to)1271-1296
    Number of pages26
    DOIs
    Publication statusPublished - 01.02.2011

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Oligomeric nucleic acids as antivirals'. Together they form a unique fingerprint.

    Cite this